Background Rectal cancer is a highly prevalent disease which needs a multidisciplinary approach to be treated. The absence of specific protocols implies a significant and unjustifiable variability among the different professionals involved in this disease. The purpose is to develop a clinical pathway based on the analysis process and aims to reduce this variability and to reduce unnecessary costs. Methods We created a multidisciplinary team with contributors from every clinical area involved in the diagnosis and treatment in this disease. We held periodic meetings to agree on a protocol based on the best available clinical practice guidelines. Once we had agreed on the protocol, we implemented its use as a standard in our institution. Every...
Introduction: The mainstay of management for locally advanced rectal cancer is chemoradiotherapy fol...
In the last two decades, treatment of rectal cancer has considerably improved in Europe. Although th...
The incidence of colorectal cancers detected at an early stage, that is stage T2 or less, has increa...
Colorectal cancer is the third most frequent cancer for men and second most frequent for women in Sw...
Purpose Introducing care pathways is seen as a method to realise patient-focussed care conform evide...
The main evidences of epidemiology, diagnostic imaging, pathology, surgery, radiotherapy, chemothera...
The purpose of the present study was to evaluate the value of discussing rectal cancer patients in a...
International audienceKnowledge of the biology and management of rectal cancer continues to improve....
Colorectal cancer is the 3rd most common malignant disease worldwide and it represents the major pub...
BACKGROUND Colorectal cancer is the fourth most common cancer in men and third most common cancer i...
Contains fulltext : 144583.pdf (publisher's version ) (Closed access)Pathological ...
Aims: With the aim of improving locoregional control, the use of preoperative chemoradiotherapy (CRT...
Background Treatment options for advanced and metastatic rectal cancer have increased during the pa...
Background: The optimal treatment sequence for patients with rectal cancer and synchronous liver met...
Background. Multidisciplinary team (MDT) conferences have been introduced into standard cancer care,...
Introduction: The mainstay of management for locally advanced rectal cancer is chemoradiotherapy fol...
In the last two decades, treatment of rectal cancer has considerably improved in Europe. Although th...
The incidence of colorectal cancers detected at an early stage, that is stage T2 or less, has increa...
Colorectal cancer is the third most frequent cancer for men and second most frequent for women in Sw...
Purpose Introducing care pathways is seen as a method to realise patient-focussed care conform evide...
The main evidences of epidemiology, diagnostic imaging, pathology, surgery, radiotherapy, chemothera...
The purpose of the present study was to evaluate the value of discussing rectal cancer patients in a...
International audienceKnowledge of the biology and management of rectal cancer continues to improve....
Colorectal cancer is the 3rd most common malignant disease worldwide and it represents the major pub...
BACKGROUND Colorectal cancer is the fourth most common cancer in men and third most common cancer i...
Contains fulltext : 144583.pdf (publisher's version ) (Closed access)Pathological ...
Aims: With the aim of improving locoregional control, the use of preoperative chemoradiotherapy (CRT...
Background Treatment options for advanced and metastatic rectal cancer have increased during the pa...
Background: The optimal treatment sequence for patients with rectal cancer and synchronous liver met...
Background. Multidisciplinary team (MDT) conferences have been introduced into standard cancer care,...
Introduction: The mainstay of management for locally advanced rectal cancer is chemoradiotherapy fol...
In the last two decades, treatment of rectal cancer has considerably improved in Europe. Although th...
The incidence of colorectal cancers detected at an early stage, that is stage T2 or less, has increa...